Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Psoriasis patients show increased rates of somatic comorbidity and psychiatric illness

Key clinical point: Skin psoriasis and somatic comorbidity was significantly associated with risk of psychiatric illness.

Major finding: Psoriasis patients with somatic comorbidities had 2.56 times the risk of psychiatric illness compared to those without psoriasis or psychiatric comorbidity; those with psoriasis with no somatic comorbidity had 1.32 times the risk of psychiatric illness.

Study details: The data come from a case-control study of 93,239 psoriasis patients from a Swedish registry and 1,387,495 matched controls from a Swedish registry.

Disclosures: The study received no outside funding. Lead author Mr. Geale disclosed personal fees from Quantify Research and Parexel International, as well as stock options and board membership for Quantify Research.

Citation:

Geale K et al. JAMA Dermatol. 2020 June 3. doi:10.1001/jamadermatol.2020.1398.